Andrijevic, David http://orcid.org/0000-0002-5703-3837
Vrselja, Zvonimir
Lysyy, Taras
Zhang, Shupei
Skarica, Mario http://orcid.org/0000-0002-2478-014X
Spajic, Ana
Dellal, David
Thorn, Stephanie L.
Duckrow, Robert B.
Ma, Shaojie http://orcid.org/0000-0002-8782-3047
Duy, Phan Q. http://orcid.org/0000-0002-4513-7348
Isiktas, Atagun U. http://orcid.org/0000-0002-5459-6810
Liang, Dan
Li, Mingfeng http://orcid.org/0000-0002-7959-6008
Kim, Suel-Kee http://orcid.org/0000-0003-0240-9304
Daniele, Stefano G.
Banu, Khadija
Perincheri, Sudhir
Menon, Madhav C.
Huttner, Anita
Sheth, Kevin N. http://orcid.org/0000-0003-2003-5473
Gobeske, Kevin T.
Tietjen, Gregory T. http://orcid.org/0000-0002-7227-2887
Zaveri, Hitten P. http://orcid.org/0000-0001-7830-0052
Latham, Stephen R.
Sinusas, Albert J. http://orcid.org/0000-0003-0972-9589
Sestan, Nenad http://orcid.org/0000-0003-0966-9619
Article History
Received: 9 September 2021
Accepted: 23 June 2022
First Online: 3 August 2022
Competing interests
: D.A., Z.V. and N.S. have disclosed these findings to the Yale Office of Cooperative Research, which has filed a patent to ensure broad use of the technology. All protocols, methods, perfusate formulations and components of the OrganEx technology remain freely available for academic and non-profit research. Although the Hemopure product was provided in accordance with a material transfer agreement between HbO2 Therapeutics and Yale University through N.S., the Company had no influence on the study design or interpretation of the results. No author has a financial stake in, or receives compensation from, HbO2 Therapeutics.